Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

Jens Kelm's Biography



Jens Kelm, CEO and Co-Founder, PreComb Therapeutics AG

Jens M. Kelm, PhD is a biotech executive and co-inventor of 3D microtissue technology with more than 20 years of experience in Biotech. He got his PhD at the Institute of Biotechnology at the ETHZ followed by a research associate position at the University Hospital Zürich. After two years he became the scientific director of the Competence Center Applied Biotechnology and Molecular Medicine (CABMM) at the University of Zürich. He is a co-founder of InSphero AG where he served as CSO/CTO as well as chairman of the Board of Directors. Currently CEO and co-founder of PreComb Therapeutics AG applying 3D tissue engineering technologies to discover novel drug combinations. Jens has generated 10 patents/applications, published more than 50 scientific publications focusing on the development and implementation of 3D models in drug discovery and regenerative medicine. and is also co-founder and committee member of the competence center for Tissue engineering for Drug Development and substance Testing (TEDD).

Jens Kelm Image

3D Microtumor-based Combinatorial Drug Discovery

Thursday, 13 June 2019 at 16:30

Add to Calendar ▼2019-06-13 16:30:002019-06-13 17:30:00Europe/London3D Microtumor-based Combinatorial Drug Discovery3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

3D tissue culture technologies for drug discovery are becoming of age. However, new 3D technologies and models are primarily used to exchange existing models to improve individual aspects in the developmental process. However, 3D models do not only reflect tissue and organ disease biology better than 2D models they allow to create novel assays to build completely new drug development processes. To take full advantage of 3D we present a 3D-based discovery processes to develop novel drug combinations.


Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com